Controlled Diet for Kidney Stone Prevention
Trial Summary
What is the purpose of this trial?
There is increasing evidence that obesity is associated with increased urinary oxalate excretion, an important risk factor for calcium oxalate stone formation. By the administration of a controlled low oxalate diet the investigators will estimate endogenous oxalate synthesis in both non-obese and obese non-kidney-stone forming adults. This study seeks to thusly increase the understanding of the relationships between obesity and endogenous oxalate synthesis to serve as a platform to develop novel therapies for stone prevention.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Controlled Diet, Dietary Intervention, Nutritional Therapy for kidney stone prevention?
Is a controlled diet for kidney stone prevention safe for humans?
How is the Controlled Diet treatment for kidney stone prevention different from other treatments?
The Controlled Diet treatment for kidney stone prevention is unique because it focuses on personalized dietary changes to reduce stone risk, rather than relying solely on medication. This approach involves adjusting fluid intake, calcium, sodium, and animal protein in the diet, tailored to each individual's specific needs and stone risk factors.147910
Research Team
Dean G Assimos, MD
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for adults aged 25-60 who are not obese (BMI <50) and have no history of kidney stones, diabetes, liver or renal diseases, bowel or other endocrine disorders. Pregnant women or those planning to become pregnant soon cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Dietary Intervention
Participants are placed on a controlled low oxalate diet to estimate endogenous oxalate synthesis
Assessment
Participants receive oral doses of 13C2-glycolate and 13C6-vitamin C to determine conversion to 13C2-oxalate and assess body morphometric indices, oxidative stress, and insulin resistance
Follow-up
Participants are monitored for safety and effectiveness after the dietary intervention
Treatment Details
Interventions
- Controlled Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor